US8197822B2 - Method for the Production of Human Immunodeficiency Virus (HIV) Proteins Utilizing Modified Vaccinia Virus Ankara (MVA) Recombinants Comprising HIV Genes Inserted into One or More Intergenic Regions (IGRs)